CT SB00218 | 2021 | General Assembly
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 22 2021 - 25% progression, died in committee
Action: 2021-01-22 - Referred to Joint Committee on Insurance and Real Estate
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 22 2021 - 25% progression, died in committee
Action: 2021-01-22 - Referred to Joint Committee on Insurance and Real Estate
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To: (1) Require the Office of Health Strategy to establish and implement health care cost growth benchmarks in this state; (2) require the Commissioner of Consumer Protection to submit a request to the federal Secretary of Health and Human Services to implement a Canadian prescription drug reimportation program in this state and, if the secretary approves such request, implement such program in this state; (3) implement the Insurance Commissioner's recommendations regarding stop-loss insurance; and (4) require the Office of Health Strategy to seek a state innovation waiver from the federal government to establish a reinsurance program in this state and, if the federal government approves such request, establish such program.
Title
An Act Concerning The Cost Of Health Care, Prescription Drug Reimportation, Stop-loss Insurance And Reinsurance.
Sponsors
Sen. Kevin Kelly [R] |
History
Date | Chamber | Action |
---|---|---|
2021-01-22 | Senate | Referred to Joint Committee on Insurance and Real Estate |
Connecticut State Sources
Type | Source |
---|---|
Summary | https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00218&which_year=2021 |
Text | https://www.cga.ct.gov/2021/TOB/S/PDF/2021SB-00218-R00-SB.PDF |